Company intelligence / Profile preview

Apotex Inc.

Toronto, Ontario, Canadaapotex.com ↗
Ownership
Private
Employees
~8000
Development stage
Other
01

Overview

Apotex is the largest Canadian-based pharmaceutical company specializing in generic medications with over 300 products selling in over 115 countries. The company has a significant presence in the United States and is a health partner of choice for the Americas.

Therapeutic areas
CardiovascularPsychiatryOphthalmologyEndocrinologyHematologyOncologyNeurologyInfectious Diseases
Modalities
Small molecule drugsBiosimilarsColony-stimulating factorsMonoclonal antibodiesSynthetic peptidesRecombinant polypeptides
Industry
Biotech
02

Drug pipeline

15 assets

Pliaglis

Approved

14 more assets in the full pipeline.

Beyond the preview

Go deeper on Apotex Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apotex Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call